Abstract -The development of recombinant DNA technology has allowed the study of the molecular pathology of inherited diseases in man. Two main molecular approaches are employed: direct study for detection of molecular defects and indirect detection by linkage analysis. A variety of new technologies and their applications have provided a powerful new tool in the diagnosis of inherited diseases.
INTRODUCTION
During the last twenty years the recombinant DNA technology has developed very powerful and sensitive techniques, which are listed in Table 1 , useful in the study and for the identification of the molecular defects of human inherited diseases.
DNA
technology has allowed an enormous increase of basic knowledge on inherited diseases and has had great effect on biodiagnostics; in general it has increased the knowledge on the human genome. The development of DNA based diagnostic tests for genetic disorders is still in progress. It will take time for experimental validation and for standardization of protocols. However their transferibility to the clinical field will depend on other factors, like the simplicity of procedures, the speed of execution and the cost of the analysis. Since 1 9 7 3 , 7 5 human genes have been mapped (ref.
1). Table 2 shows all the genes mapped in the 1st edition of "Human Gene Mappingt'. Every year, during the Human Gene Mapping conference, the DNA Committee has three primary responsibilities: a) summarizing information on cloned and mapped human genes, b) summarizing information on polymorphisms detected by using molecular techniques, and c) the development of a nomenclature appropriate for loci identified by anonymous DNA probes and assignment of symbols to those loci. Since 1 9 8 3 , these data have been collected also on Database to facilitate and to speed up the access (ref. 1). There are also others Database with the list of papers on cloned sequences both for genes and for anonimous sequences (ref. 2 ) . The number and chromosome distribution of cloned sequences and polymorphisms are shown in Fig. 1 and Table 3 (10th edn of Human Gene Mapping).
The nature of the genetic lesion has now been established at the DNA level in many diseases: the majority , 58, are due to deletions, 5 2 are caused by point mutations and 3 4 by insertions, duplications and gene rearrangements (ref. The advent of molecular biology techniques has expanded our ability to diagnose inherited diseases. In fact , it is possible to carry out the analysis at the DNA level and it is not necessary to know the gene product, which gives three advantages: a) the analysis should be done for example on limphocytes and not only on the disease target cells, b) it allows carrier detection and, c) it allows the molecular defect characterization. A condition for the diagnostic use of RFLPs is a strong association of the polymorphism with the disease gene. The probability of recombinational events will depend on their distance. The genetic distance is expressed as recombination fraction and varies from 0 to 0.5 morgan (M). Also for close genes, recombination might occurr between the RFLPs and the structural gene; to prevenE false negatives it is advisable to use more than one RFLP. The degree of linkage must be established by extensive studies on families.
RFLPs analysis allows to score the non random association between a disease allele and a polymorphic locus (linkage disequilibrium). To be informative, the family must show heterozigosity for the analysed polymorphism.
RFLPs analysis is usually carried out by Southern blotting technique (ref. 8): peripheral blood limphocytes DNA is extracted and digested by restriction endonucleases which cut the DNA at specific palindromic sequences. The resulting fragments are then separated by electrophoresis in an agarose gel, denatured and blotted onto nylon membranes. DNA fragments are then hybridized with isotopically labeled complementary probes.
In Fig.4 a prenatal diagnosis based on RFLP analysis is shown. 
DIRECT DETECTION
The direct detection is possible when the affected gene is known and its structure is well defined. This approach is very sensitive and quick, in particular for those diseases in which the molecular defect shows little variability. In fact, the higher the heterogeneity of mutations, the more complex the design of diagnostic approach. The direct approach is feasible in the diagnostic field only after the definition of the different kinds of mutations in the various populations. Thus, when the complexity of genetic alterations is vast or when research is still at preliminary stages, the direct detection is used in combination with RFLPs analysis. The rapid expansion of DNA technology and the development of new more sensitive techniques has remarkably increased the usefulness and potentiality of direct approach in prenatal diagnosis and carrier screening.
The most appropriate diagnostic methods will be chosen for each kind of disease even combining different techniques.
As we reported, at the DNA level there should be many different kinds of alterations: extensive deletions, insertions and rearrangements, can be scored on Southern blots as a band shift. On the other hand, if we consider smaller deletions/insertions or mutations, such as point mutations, the analysis by Southern blotting is not very sensitive because it is feasible only when the mutation alters a restriction enzyme site. In the last few years the introduction of the Polymerase Chain Reaction (PCR) technique (ref. 9) has advantaged the possibility to carry out genetic disease diagnoses that were impossible using conventional methods.
The PCR is a powerful method that allows to amplify over a millionfold specific DNA target single copy sequences. The reaction principles are shown ia Fig. 5 This strategy is very appropriate in these patients because of the large percentage of cases (about 60%) due to the presence of heterogeneous intragenic deletions.
In those cases in which the mutation is unknown, RFLP analysis coupled to PCR can be used. By cutting specific amplified DNA with a restriction enzyme it is possible to directly analyse the RFLP on a agarose gel, without the use of radioisotopes. This strategy takes less than one day in comparison with longer Southern blotting and hybridization method. In Figure 6 is shown an amplification for detection of KM-19 polymorpfism for prenatal diagnosis in a family with Cystic Fibrosis.
NEW TECHNOLOGIES
We will briefly consider the most recent and significant technologies and we will outline the more advantageous aspects. In general these new technologies have the advantage of enhancing the resolution and the diagnostic potentiality and to increase the basic knowledge on research and characterization of new mutations and polymorphisms.
DNA sequencing
The two most used DNA sequencing methods are the chemical 
Chemical cleavage
This procedure allows detection, definition and localization of single base pair mutations. Labeled heteroduplex DNA molecules containing mismatched base pairs, are incubated with osmium tetroxide or hydroxylamine and then treated with piperidine to cleave the DNA at the modified mismatched base. DNA cleavage is detected by denaturing gel elecrophoresis (ref. 20) .
Denaturing gradient gel electrophoresis (DGGE)

DGGE
is very useful for the initial screening and detection of new polymorphisms or mutations, before precisely defining the nature of nucleotidic variation. This tecnique allows the resolution of DNA molecules differing by single base changes. Using a polyacrilamide gel containing a linear gradient of DNA denaturants (urea/formamide) (ref.21) it is possible to resolve mutant from normal homoduplexes because of the different melting properties of the DNA molecules. These different melting behaviors can be increased by adding a GC-rich clamp ending a primer (ref. 22, 23) .
Single strand conformation polymorphisms (SSCP)
This technique, described by Orita et a1 in 1989, (ref. 24, 25 ) is a method to detect base changes on amplified or cloned DNA sequences. Specific DNA regions labeled and denatured are analysed in non-denaturing polyacrilamide gels.
The electrophoretic mobility of single-stranded molecules will depend on their size and also on their sequence allowing detection of allelk variants or mutations.
RNAseA mismatch analysis
This strategy is based on the capability of the enzyme to digest only not hybridized RNA molecules. Thus it is possible to identify the site of a lesion in a gene by hybridizing a normal RNA molecule to the RNA or DNA to be analyzed. The mismatch region is identified by gel elecrophoresis after the R N A s e A cleavage (ref. 26).
Pulse field gel electrophoresis (PFGE)
PFGE is a technique for resolving megabase restriction fragment length variations. By alternating the electric field, DNAs are able to reorient and differentially move through the gel (ref. 27 ). Conventional elecrophoresis does not resolve DNA fragments larger than 50 kb. This technique has many applications: a) detection of polymorphisms (ref. 
CONCLUSIONS
DNA technology has led possible the diagnosis of many genetic diseases. It will play an increasing role in research and diagnosis of a growing number of inherited diseases, that will become amenable. The increase of knowledge and the technical development will be exploited and quickly transferred to the clinical laboratories. However, the widespread diffusion and the transferibility of these technologies will need to develop protocols and to take care of possible ethical problems.
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